CVS: CVS Health Corporation Stock

SIC 5912 – Drug Stores and Proprietary Stores

Valuation
Market Cap ($M) 97,026.46
Enterprise Value ($M) 149,224.46
Book Value ($M) 76,636.00
Book Value / Share 60.90
Price / Book 1.27
NCAV ($M) -105,234.00
NCAV / Share -83.62
Price / NCAV -0.92

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.12

Liquidity (mrq)
Quick Ratio 0.63
Current Ratio 0.86

Balance Sheet (mrq) ($M)
Current Assets 67,858.00
Assets 249,728.00
Liabilities 173,092.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 356,623.00
Operating Income 14,073.00
Net Income 8,344.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 13,426.00
Cash from Investing -20,889.00
Cash from Financing 2,683.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.14 0.13
01-26 13G/A BlackRock Inc. 6.80 -9.98

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-23 567,405 3,633,982 15.61
2024-02-22 669,016 4,748,059 14.09
2024-02-21 831,058 18,723,154 4.44
2024-02-20 698,319 6,924,020 10.09

(click for more detail)


Financial data and stock pages provided by
Fintel.io


Finpedia: CVS Health Corp